^
BIOMARKER:

BRAF V600

i
Other names: BRAF, B-raf proto-oncogene, B-raf proto-oncogene, Serine/threonine kinase, V-Raf murine sarcoma viral oncogene homolog B, Serine/threonine-protein kinase B-Raf, Proto-oncogene B-Raf, BRAF1, RAFB1, B-raf proto-oncogene Serine/threonine-protein kinase, Murine sarcoma viral (V-Raf) oncogene homolog B1, B-raf serine/threonine-protein, 94 KDa B-raf protein, B-RAF1




Show legend

Include preclinical:
Melanoma
Cutaneous Melanoma
Colorectal Cancer
Rectal Cancer
Thyroid Gland Papillary Carcinoma
Non Small Cell Lung Cancer
Glioma
Ganglioglioma
Lymphoma
Ovarian Cancer
Ocular Melanoma
Brain Cancer
Astrocytoma
Multiple Myeloma
Cholangiocarcinoma
Thyroid Gland Carcinoma
Pancreatic Cancer
Thyroid Gland Anaplastic Carcinoma
Sarcoma
Glioblastoma
Anaplastic Astrocytoma
Pancreatic Ductal Adenocarcinoma
Solid Tumor
Hairy Cell Leukemia
Lung Adenocarcinoma
Colon Cancer
vemurafenib
nivolumab + ipilimumab
trametinib + dabrafenib
cetuximab + encorafenib
PD1 inhibitor
pembrolizumab + trametinib
pembrolizumab + dabrafenib
Immunotherapy
BRAF inhibitor + MEK inhibitor
panitumumab + encorafenib
FORE-8394
vemurafenib + cobimetinib
binimetinib + encorafenib
dabrafenib
vemurafenib + HL-085
BGB-283
trametinib + dabrafenib + PDR001
cetuximab + vemurafenib
trametinib + dabrafenib + panitumumab
atezolizumab + vemurafenib + cobimetinib
trametinib
cetuximab + alpelisib + encorafenib
cobimetinib + RG6185
encorafenib
pembrolizumab + binimetinib + encorafenib
lifileucel
pembrolizumab + trametinib + dabrafenib
ABM-1310
nivolumab + ipilimumab + binimetinib + encorafenib
atezolizumab
vemurafenib + toripalimab-tpzi
pembrolizumab + vemurafenib
vemurafenib + panitumumab
CH4987655
dabrafenib + panitumumab
trametinib + osimertinib + dabrafenib
binimetinib
pembrolizumab + NLG8189
nivolumab + NLG8189
atezolizumab + cobimetinib
cetuximab + binimetinib + encorafenib
pembrolizumab
nivolumab
vorinostat
trametinib + dabrafenib + phenformin
vemurafenib + everolimus
AZD6738
RTB101
selumetinib
olaparib + AZD6738
ipilimumab + talimogene laherparepvec
selumetinib + RTB101